Dividing our cohort into diagnostic subgroups allowed for clinically relevant comparisons between “double-seronegative” myelitis and patients meeting diagnostic criteria for AQP4-IgG seropositive NMOSD and MOGAD. The gene discussed is AQP4; the disease is myelitis.